InvestorsHub Logo
Followers 43
Posts 5450
Boards Moderated 0
Alias Born 11/15/2013

Re: Blue Fin post# 393274

Thursday, 09/15/2022 7:44:08 PM

Thursday, September 15, 2022 7:44:08 PM

Post# of 403121
I agree we are likely soon to see a nasal version of Brilacidin developed for onset use as a broad spectrum anti-viral treatment.
Per George Mason university- Brilacidin is thus able to exert a combined protective effect by decreasing both viral and inflammatory load.

Freedom is not free.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News